Most Recent
The developer of a Canola seed hybrid tolerant to herbicide has lost a bid for seed grower Nuseed to relabel its products, which are already stocked in 361 retail locations.
Sydney hospitality mogul Justin Hemmes has prevailed in a trade mark stoush with Brisbane restaurant Establishment 203.
Two insurers have come up short in their appeal of a ruling that put them on the hook for the costs of Opal Tower consultant engineer WSP in a class action by residents.
Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.
Seven is facing another workplace lawsuit by a former journalist, with former Spotlight reporter Amelia Saw accusing the TV network of general protections breaches under the Fair Work Act.
Medical device supplier Medtronic has been socked with a $22 million penalty after it supplied non-compliant bone graft kits to hospitals, in what is the largest penalty under the Therapeutics Good Act.
A second law firm has filed a class action against Harvey Norman alleging it sold extended warranties to customers that had “no real value”.
Insurers have won a challenge to a declaration that engineering firm CIMIC could make claims under policies for costs arising from corruption cases, including a $32 million class action settlement.
Two failed shareholder class actions against the Commonwealth Bank of Australia want to delay paying the bank's costs until after their 62-ground appeal is heard.
Cosmetics maker Self Care has won its case against companies with ties to China that were found to have sold counterfeit versions of its popular Freezeframe anti-ageing creams.